Mouth Ulcer Treatment Market Overview
The Mouth Ulcer Treatment market is projected to reach USD 1.13 Billion by 2030 at 3.90% CAGR during the forecast period 2022-2030. Mouth ulcers are painful sores that develop in the oral cavity's mucous membrane, making it difficult to chew, bite, or eat. Stress, illness, injury, allergies, and other conditions can cause a mouth ulcer, which causes excruciating agony. The rising usage of synthetics in oral products such as toothpaste, as well as an increase in unhealthy lifestyles, such as increased consumption of junk food and smoke, are propelling the market forward. Mouth ulcers can be avoided by preventing tissue injury, avoiding irritating foods, and keeping good dental hygiene. Aside from the traditional way, oral ulcers are treated using a variety of medications. The expansion of this mouth ulcer treatment market is being driven by an older population and an increase in the occurrence of mouth ulcers. Mouth ulcers, also known as canker sores, are painful sores that develop on the lips, cheeks, tongue, floor, the roof of the mouth, and gums. Some individuals may find it difficult to eat, drink, or brush their teeth due to mouth ulcers. Most mouth ulcers are benign and recurrent, clearing up on their own within 1-2 weeks. Acidic foods, biting the tongue or inside of the cheek, braces, poor-fitting dentures, and other apparatus that rub against the mouth and gums, vitamin deficiency, stress, anxiety, infections, and maybe a sign of other diseases such as Crohn's disease, celiac disease, or HIV are all common causes of mouth ulcers.
The mouth ulcer treatment market has been segmented on basis of drug type, formulation, and indication. On basis of drug type, the market is segmented into corticosteroid, antihistamine, antimicrobial, analgesic, and anesthetic. Based on formulation, the market is segmented into gel, mouthwash, ointment, spray, and lozenges. Based on indication market is segmented into Aphthous Stomatitis, Oral Lichen Planus and Others.
Key players in the mouth ulcer treatment market are Pfizer, Inc., Church & Dwight Co., Inc., 3M, Taro Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, BLISTEX, INC., GlaxoSmithKline plc., ECR Pharmaceuticals, Sannova, Reckitt Benckiser, Sunstar, Blairex Laboratories, Sanjin Pharmaceutical, Joincare Pharmaceutical, Sinclair Pharma, Colgate-Palmolive Company
Regional Market Summary
Global Mouth Ulcer Treatment Market Share (%), by Region, 2018
Source: World Health Organization (WHO)
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The mouth ulcer treatment market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The mouth ulcer treatment market in the Middle East and Africa has been segmented into the Middle East and Africa.
On the basis of region, the market is segmented into North America, Europe, Asia-Pacific, and the Middle East and Africa. North America market is anticipated to dominate the mouth ulcer treatment market due to advanced technology made in diagnostic procedures of oral and dental care. Growing awareness among consumers regarding the availability of mouth ulcer treatment is the key share to increase the growth of the market in North America. Europe is anticipated to drive the growth of mouth ulcer treatment in upcoming years due to increasing incidences of an aging population suffering from mouth ulcer. Asia-Pacific is projected to register a robust growth due to increasing initiatives of government regarding mouth ulcer and increasing patients with mouth ulcer cases. The Middle East and Africa is expected to account for the lowest market share in the market due to lack of advanced technology and poor medical facilities in developing economies in this region.Recent Development
Manx Healthcare introduced Oral Soothe and Sore Throat 0.15 percent w/v mouthwash in September 2021, an over-the-counter product used to treat mouth and throat pain caused by a variety of medical issues, such as dental surgery, tonsillitis, gum disease, mouth ulcers, and other mouth and throat conditions.
GELX ORAL GEL, a Zinc-Taurine bioactive barrier therapy for the management and reduction of oral discomfort associated with oral mucositis, was launched in May 2020 by US WorldMeds, LLC.
Market of Mouth Ulcer Treatment, by Drug Type
Market of Mouth Ulcer Treatment, by Formulation
Market of Mouth Ulcer Treatment, by Indications
- Aphthous Stomatitis
- Oral Lichen Planus
Market of Mouth Ulcer Treatment, by Region
- North America
- South America
- Western Europe
- Rest of Western Europe
- Eastern Europe
- South Korea
- Rest of Asia-Pacific
Middle East & Africa
2030: USD 1.13 Billion
Value (USD Billion)
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Drug Type, Formulation, and Indication
North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Pfizer, Inc., Church & Dwight Co., Inc., 3M, Taro Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, BLISTEX, INC., GlaxoSmithKline plc., ECR Pharmaceuticals, Sannova, Reckitt Benckiser, Sunstar, Blairex Laboratories, Sanjin Pharmaceutical, Joincare Pharmaceutical, Sinclair Pharma, Colgate-Palmolive Company
Key Market Opportunities
· Growing awareness among consumers regarding the availability of mouth ulcer treatment is the key share to increase the growth of the market in North America
· increasing incidences of an aging population suffering from mouth in Europe
Key Market Drivers
· Increasing use of synthetics in oral items such as toothpaste
· Growing unhealthy lifestyle, including high consumption of junk food and tobacco
Frequently Asked Questions (FAQ) :
Casual approach taken by most patients towards mouth ulcers is the key restraint on the market, as this stops patients from seeking out recognized medication.
Mouth Ulcer Treatment Market is expected to exhibit a steady 3.90% CAGR over the forecast period from 2022 to 2030.
Growing prevalence of mouth ulcers is likely to be a major driver for the market.
Americas hold the largest share in the global mouth ulcer treatment market.
Leading players in the Mouth Ulcer Treatment Market include BLISTEX Inc., 3M, and Pfizer, among others.
Key Questions Answered
Request Free Sample
- ✅Global Market Outlook
- ✅In-depth analysis of global and regional trends
- ✅Analyze and identify the major players in the market, their market share, key developments, etc.
- ✅To understand the capability of the major players based on products offered, financials, and strategies.
- ✅Identify disrupting products, companies, and trends.
- ✅To identify opportunities in the market.
- ✅Analyze the key challenges in the market.
- ✅Analyze the regional penetration of players, products, and services in the market.
- ✅Comparison of major players’ financial performance.
- ✅Evaluate strategies adopted by major players.
Why Choose Market Research Future?
Speak to Analyst
- ✅Vigorous research methodologies for specific market.
- ✅Knowledge partners across the globe
- ✅Large network of partner consultants.
- ✅Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- ✅Trusted by fortune 500 companies/startups/universities/organizations
- ✅Large database of 5000+ markets reports.
- ✅Effective and prompt pre- and post-sales support.